The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

 

Quest Diagnostics Inc

NYSE: DGX
Last

(U.S.) $63.78

Today's change+0.86 +1.37%
Updated December 17 4:01 PM EST. Delayed by at least 15 minutes.
 

Quest Diagnostics Inc

NYSE: DGX
Last

(U.S.) $63.78

Today's change+0.86 +1.37%
Updated December 17 4:01 PM EST. Delayed by at least 15 minutes.

Quest Diagnostics Inc up (U.S.)$0.86

Quest Diagnostics Inc closed up Wednesday by (U.S.)$0.86 or 1.37% to (U.S.)$63.78. Shares have lost 0.75% over the last five days, but sit 3.45% below their 52-week high. This security has outperformed the S&P 500 by 6.08% during the last year.

Key company metrics

  • Open(U.S.) $63.06
  • Previous close(U.S.) $62.92
  • High(U.S.) $63.90
  • Low(U.S.) $62.76
  • Bid / Ask(U.S.) $60.16 / (U.S.) $66.96
  • YTD % change+19.13%
  • Volume1,284,619
  • Average volume (10-day)1,523,212
  • Average volume (1-month)1,361,208
  • Average volume (3-month)1,619,798
  • 52-week range(U.S.) $50.46 to (U.S.) $66.06
  • Beta0.76
  • Trailing P/E18.35×
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend(U.S.) $1.32
  • Dividend yield2.07%
  • Trailing EPS(U.S.) $3.48
Updated December 17 4:01 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+7.44%

Based on its net profit margin of 7.44%, Quest Diagnostics Inc is less effective than other companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX2.54%Sector:HealthcareIndustry:Healthcare Facilities
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2014Q2/2014Q1/2014Q4/2013
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201409/30/2014Jun 30, 201406/30/2014Mar 31, 201403/31/2014Dec 31, 201312/31/2013
Revenue1,9041,9021,7461,756
Total other revenue--------
Total revenue1,9041,9021,7461,756
Gross profit733732653694
Total cost of revenue1,1711,1701,0931,062
Total operating expense1,6481,6401,5381,487
Selling / general / administrative437434411423
Research & development--------
Depreciation / amortization24252220
Interest expense (income), net operating--------
Unusual expense (income)161012-18
Other operating expenses, total0100
Operating income256262208270
Interest income (expense), net non-operating-42-42-40-40
Gain (loss) on sale of assets--------
Other--------
Income before tax221229176238
Income after tax139142111151
Income tax, total82876586
Net income129133104143
Total adjustments to net income-10-1-1
Net income before extra. items129133104143
Minority interest-10-9-7-8
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items128133103143
Inc. avail. to common incl. extra. items128133103142
Diluted net income128133103142
Dilution adjustment--------
Diluted weighted average shares145145145148
Diluted EPS excluding extraordinary itemsvalue per share0.880.920.710.97
Dividends per sharevalue per share0.330.330.300.30
Diluted normalized EPSvalue per share0.950.960.760.89